Phenylpyrrole derivatives and their use as antipsychotic agents
AssigneeSmithKline Beecham Corporation
InventorsMichael Stewart Hadley, Christopher Norbert Johnson, Geoffrey Stemp
Life of this patent
Estimating the term…
Loading patent…
AssigneeSmithKline Beecham Corporation
InventorsMichael Stewart Hadley, Christopher Norbert Johnson, Geoffrey Stemp
Estimating the term…
This invention relates to compounds of formula (I): ##STR1## wherein R.sup.1 represents C.sub.1-4 alkyl; and R.sup.2, R.sup.3, R.sup.4 and R.sup.5 each independently represent hydrogen, halogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, C.sub.1-4 alkoxyC.sub.1-4 alkyl, C.sub.1-4 alkylsulphonyl, trifluoromethylsulphonyl; optionally substituted arylsulphonyl, optionally substituted heteroarylsulphonyl, optionally substituted aralkylsulphonyl, optionally substituted heteroaralkylsulphonyl, nitro, cyano, amino, mono- or di-alkylamino, trifluoromethyl, trifluoromethoxy, hydroxyl, hydroxyC.sub.1-4 alkyl, C.sub.1-4 alkylthio, C.sub.1-4 alkanoyl, C.sub.1-4 alkoxycarbonyl, aminosulphonyl, or mono- or diC.sub.1-4 alkylaminosulphonyl; or R.sup.1 and R.sup.2 together form a linking chain --(CH.sub.2).sub.m Op; (wherein m is 2 to 4 and p is zero or 1) which chain may be optionally substituted by one or two C.sub.1-4 alkyl groups; and Y represents a group of formula (.alpha.): ##STR2## wherein each of n and m independently represent an integer from 1 to 3; and salts thereof, having activity at dopamine receptors and potential utility in the treatment of psychoses such as schizophrenia.
A compound of formula (I):
Dependencies are inferred from the claim text.